Following a common theme of Hepatitis C-related stocks running together, Achillion...

|About: Achillion Pharmaceuticals... (ACHN)|By:, SA News Editor

Following a common theme of Hepatitis C-related stocks running together, Achillion Pharmaceuticals (ACHN +12.1%) rallies strongly after Israel-based BioLineRX announces a major development deal. Other Hep-C players to watch: INHX, IDIX, VRTX.